AI platform for clinical trial acceleration and real-world neurology evidence
NeuroDiscovery AI runs a neurology-specialized platform built on a proprietary multimodal LLM trained on millions of patient records. The tech stack reflects a dual-track operation: modern web foundations (React, Next.js) paired with enterprise healthcare infrastructure (DICOM, PACS, HL7) and substantial ML depth (PyTorch, TensorFlow, spaCy, Transformers, multiple LLM variants). Active hiring spans data, research, and engineering roles, with acute pain points in data mapping and ETL—suggesting the platform is scaling data connectors across fragmented health systems faster than internal tooling can support.
NeuroDiscovery AI builds a clinical AI platform targeting neurology practices and trial sponsors. The company operates as a neurology-focused data and analytics business, pulling real-world patient data from large U.S. neurology practice groups, applying proprietary machine learning to accelerate clinical trial recruitment and generate real-world evidence for regulatory use. The product surface spans patient analytics, imaging workflows (DICOM/PACS integration), and outcome studies. Founded in 2023 with headquarters in Atlanta, the company is currently scaling toward mid-market clinical and pharmaceutical customers.
Frontend: React, Next.js, Angular, Vue. ML/NLP: PyTorch, TensorFlow, spaCy, NLTK, Transformers, GPT, Llama 2, Mistral, TruLens. Healthcare: DICOM, PACS, HL7. Data: SQL, Elasticsearch, Apache Airflow, Talend. Cloud: AWS, GCP, Azure.
Current projects: next-generation imaging interfaces for neurological workflows, multimodal research, patient analytics at scale, revenue-generating patient recruitment, data validation frameworks, ETL issue resolution, and epidemiological outcome studies.
Other companies in the same industry, closest in size